19 November 2015
The prostate cancer team at University College Hospital has won a leading health industry award for innovation in diagnosing and treating prostate cancer.
The team targeted better diagnosis by taking a fresh look at the whole patient pathway, using methods that require fewer but more accurate biopsies. They also pioneered treatments – called focal therapy – that are cheaper, can be done in a day–case setting with quick recovery and carry significantly fewer long-term side-effects compared to traditional surgery or radiotherapy, such as incontinence and impotence. The new approach was shortlisted in the acute sector innovation category for the Health Service Journal Awards, and last night the team – accompanied by UCLH Chief Executive Sir Robert Naylor and Chairman Richard Murley – were named winners at the awards ceremony.
Professor Kathy Pritchard-Jones, Chief Medical Officer, London Cancer, said: “I am delighted to see the team at UCLH recognised for their efforts in improving care and services for patients with prostate cancer. We are already seeing improved outcomes and fewer complications for patients across the system, including helping partner trusts to provide these innovations in care closer to home for patients. This award is thoroughly well deserved.”
Earlier this year, the same team won the BMJ award for the Innovation category for the same work and were recently ‘highly commended’ by the NIHR for Surgical Research after being shortlisted for the NIHR CREST award.